{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:25:20Z","timestamp":1792182320289,"version":"4.4.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ijcard.2017.12.102","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T01:15:11Z","timestamp":1521681311000},"page":"122-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["A systematic review of clozapine-induced myocarditis"],"prefix":"10.1016","volume":"259","author":[{"given":"Brandi L.","family":"Bellissima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4443-7963","authenticated-orcid":false,"given":"Malcolm D.","family":"Tingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Cicovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alawami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kenedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2017.12.102_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archpsyc.1993.01820140007001","article-title":"Epidemiological catchment area prospective 1-year prevalence rates of disorders and services","volume":"50","author":"Regier","year":"1993","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.ijcard.2017.12.102_bb0010","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1176\/appi.ajp.158.4.518","article-title":"Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials","volume":"158","author":"Chakos","year":"2001","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.ijcard.2017.12.102_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/epirev\/mxn001","article-title":"Schizophrenia: a concise overview of incidence, prevalence, and mortality","volume":"30","author":"McGrath","year":"2008","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.ijcard.2017.12.102_bb0020","series-title":"The Global Burden Of Disease: A Comprehensive Assessment of Mortality and Disability From Diseases, Injuries, and Risk Factors in 1990 and projected to 2020","year":"1996"},{"issue":"Suppl. 12","key":"10.1016\/j.ijcard.2017.12.102_bb0025","first-page":"47","article-title":"Suicide and schizophrenia: clozapine and the InterSePT study. International Clozaril\/Leponex suicide prevention trial","volume":"60","author":"Meltzer","year":"1999","journal-title":"The Journal of Clinical Psychiatry."},{"issue":"9690","key":"10.1016\/j.ijcard.2017.12.102_bb0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ijcard.2017.12.102_bb0035","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1345\/aph.1K662","article-title":"Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand","volume":"42","author":"Wheeler","year":"2008","journal-title":"Ann. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijcard.2017.12.102_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF01064682","article-title":"Clinical profile of clozapine: adverse reactions and agranulocytosis","volume":"63","author":"Lieberman","year":"1992","journal-title":"The Psychiatric quarterly."},{"issue":"3","key":"10.1016\/j.ijcard.2017.12.102_bb0045","first-page":"170","article-title":"Sudden death during treatment with clozapine (Leponex)","volume":"142","author":"Vesterby","year":"1980","journal-title":"Ugeskr. Laeger"},{"issue":"9193","key":"10.1016\/j.ijcard.2017.12.102_bb0050","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","article-title":"Myocarditis and cardiomyopathy associated with clozapine","volume":"354","author":"Kilian","year":"1999","journal-title":"Lancet"},{"issue":"1\u20133","key":"10.1016\/j.ijcard.2017.12.102_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejphar.2008.06.088","article-title":"Clozapine-induced myocarditis: role of catecholamines in a murine model","volume":"592","author":"Wang","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijcard.2017.12.102_bb0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0920-9964(95)00047-X","article-title":"Myocarditis under therapy with clozapine","volume":"17","author":"Bandelow","year":"1995","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0065","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0447.1985.tb01268.x","article-title":"Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12years","volume":"71","author":"Juul Povlsen","year":"1985","journal-title":"Acta Psychiatr. Scand."},{"issue":"7","key":"10.1016\/j.ijcard.2017.12.102_bb0070","first-page":"619","article-title":"ECG changes developing during clozapine treatment","volume":"147","author":"Beier","year":"1985","journal-title":"Ugeskr. Laeger"},{"issue":"5","key":"10.1016\/j.ijcard.2017.12.102_bb0075","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1600-0447.1988.tb05164.x","article-title":"The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13years","volume":"77","author":"Lindstrom","year":"1988","journal-title":"Acta Psychiatr. Scand."},{"issue":"1","key":"10.1016\/j.ijcard.2017.12.102_bb0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/jat\/16.1.54","article-title":"Clozapine tissue concentrations following an apparent suicidal overdose of Clozaril","volume":"16","author":"Meeker","year":"1992","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.ijcard.2017.12.102_bb0085","series-title":"Current Problems in Pharmacovigilance","first-page":"9","article-title":"Committee on safety of M. Myocarditis with antipsychotics: recent cases with clozapine (Clozaril)","volume":"19","year":"1993"},{"issue":"28","key":"10.1016\/j.ijcard.2017.12.102_bb0090","first-page":"4151","article-title":"Allergic myocarditis in clozapine treatment","volume":"156","author":"Jensen","year":"1994","journal-title":"Ugeskr. Laeger"},{"issue":"24","key":"10.1016\/j.ijcard.2017.12.102_bb0095","first-page":"3026","article-title":"Clozapine and myocarditis","volume":"115","author":"Lilleng","year":"1995","journal-title":"Tidsskr. Nor. Laegeforen."},{"issue":"1","key":"10.1016\/j.ijcard.2017.12.102_bb0100","first-page":"46","article-title":"Perimyocarditis under clozapin (Leponex)","volume":"24","author":"Khalil","year":"1997","journal-title":"Psychiatr. Prax."},{"issue":"4","key":"10.1016\/j.ijcard.2017.12.102_bb0105","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00002826-199708000-00007","article-title":"Clozapine induced polyserositis","volume":"20","author":"Catalano","year":"1997","journal-title":"Clin. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.ijcard.2017.12.102_bb0110","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1080\/j.1440-1614.2000.0822n.x","article-title":"Myocarditis associated with clozapine treatment","volume":"34","author":"Degner","year":"2000","journal-title":"Australian & New Zealand Journal of Psychiatry."},{"issue":"4","key":"10.1016\/j.ijcard.2017.12.102_bb0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00004714-200108000-00005","article-title":"Myocarditis related to clozapine treatment","volume":"21","author":"Hagg","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.ijcard.2017.12.102_bb0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJM200107193450317","article-title":"Myocarditis and cardiomyopathy associated with clozapine use in the United States [5]","volume":"345","author":"La Grenade","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1440-1614.2001.0884a.x","article-title":"Clozapine rechallenge after myocarditis","volume":"35","author":"Reid","year":"2001","journal-title":"Australian & New Zealand Journal of Psychiatry."},{"issue":"6","key":"10.1016\/j.ijcard.2017.12.102_bb0130","first-page":"779","article-title":"Reversible myocarditis in a patient receiving clozapine","volume":"53","author":"Kirpekar","year":"2001","journal-title":"Indian Heart J."},{"issue":"9","key":"10.1016\/j.ijcard.2017.12.102_bb0135","first-page":"1185","article-title":"Antipsychotic clozapine (Clozaril): myocarditis and cardiovascular toxicity. CMAJ","volume":"166","author":"Wooltorton","year":"2002","journal-title":"Can. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.ijcard.2017.12.102_bb0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1440-1614.2002.0988f.x","article-title":"Clozapine associated pericarditis and elevated troponin I","volume":"36","author":"Kay","year":"2002","journal-title":"Australian & New Zealand Journal of Psychiatry."},{"issue":"5","key":"10.1016\/j.ijcard.2017.12.102_bb0145","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00414-004-0464-1","article-title":"Sudden cardiac death due to hypersensitivity myocarditis during clozapine treatment","volume":"118","author":"Fineschi","year":"2004","journal-title":"Int. J. Legal Med."},{"issue":"11\u221212","key":"10.1016\/j.ijcard.2017.12.102_bb0150","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1080\/j.1440-1614.2004.01481.x","article-title":"Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service","volume":"38","author":"Reinders","year":"2004","journal-title":"Australian & New Zealand Journal of Psychiatry."},{"issue":"5","key":"10.1016\/j.ijcard.2017.12.102_bb0155","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1378\/chest.126.5.1703","article-title":"Clozapine-induced hypersensitivity myocarditis","volume":"126","author":"Pieroni","year":"2004","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/1044546041649039","article-title":"Pericarditis and polyserositis as a side effect of clozapine in an adolescent girl","volume":"14","author":"Branik","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology."},{"issue":"1","key":"10.1016\/j.ijcard.2017.12.102_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/j.1440-1614.2006.01748_1.x","article-title":"Correspondence: clozapine and heart in the hunter region","volume":"40","author":"Tirupati","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.ijcard.2017.12.102_bb0170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.mjt.0000212704.79248.3d","article-title":"Clozapine induced myopericarditis: early recognition improves clinical outcome","volume":"13","author":"Razminia","year":"2006","journal-title":"Am. J. Ther."},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0175","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1176\/appi.ajp.163.2.204","article-title":"Myocarditis during clozapine treatment","volume":"163","author":"Merrill","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2006.01.033","article-title":"Clozapine induced myocarditis: a rare but fatal complication","volume":"112","author":"Kakar","year":"2006","journal-title":"Int. J. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2017.12.102_bb0185","first-page":"503","article-title":"Myocarditis from clozapine","volume":"23","author":"Martinez Rey","year":"2006","journal-title":"An. Med. Interna"},{"issue":"5","key":"10.1016\/j.ijcard.2017.12.102_bb0190","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/jcp.0b013e31814e5e68","article-title":"Early recognition of clozapine-induced myocarditis","volume":"27","author":"Annamraju","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.ijcard.2017.12.102_bb0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00002018-200730010-00005","article-title":"Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993\u20132003","volume":"30","author":"Haas","year":"2007","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.ijcard.2017.12.102_bb0200","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/10976640601015458","article-title":"Myocarditis associated with clozapine studied by cardiovascular magnetic resonance","volume":"9","author":"Belloni","year":"2007","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"4","key":"10.1016\/j.ijcard.2017.12.102_bb0205","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/10398560701348601","article-title":"Acute myocarditis associated with clozapine","volume":"15","author":"Varambally","year":"2007","journal-title":"Australasian Psychiatry."},{"issue":"5","key":"10.1016\/j.ijcard.2017.12.102_bb0210","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/0269881107082136","article-title":"Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives","volume":"22","author":"Lang","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"1283","key":"10.1016\/j.ijcard.2017.12.102_bb0215","first-page":"68","article-title":"Clozapine and myocarditis: a case series from the New Zealand intensive medicines monitoring programme","volume":"121","author":"Hill","year":"2008","journal-title":"N. Z. Med. J."},{"issue":"5","key":"10.1016\/j.ijcard.2017.12.102_bb0220","first-page":"434","article-title":"Clozapine-induced myocarditis","volume":"42","author":"Caetano","year":"2008","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.ijcard.2017.12.102_bb0225","first-page":"243","article-title":"Clozapine-induce myocarditis","volume":"37","author":"Espino","year":"2009","journal-title":"Actas Espanolas de Psiquiatria."},{"issue":"5","key":"10.1016\/j.ijcard.2017.12.102_bb0230","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/10398560903176941","article-title":"Monitoring of clozapine-induced myocarditis","volume":"17","author":"Caetano","year":"2009","journal-title":"Australasian Psychiatry."},{"issue":"5","key":"10.1016\/j.ijcard.2017.12.102_bb0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/10398560902965302","article-title":"Clozapine rechallenge after myocarditis","volume":"17","author":"Jayathilake","year":"2009","journal-title":"Australasian Psychiatry."},{"issue":"1","key":"10.1016\/j.ijcard.2017.12.102_bb0240","first-page":"19","article-title":"Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease","volume":"30","author":"Masopust","year":"2009","journal-title":"Neuroendocrinol. Lett."},{"issue":"6","key":"10.1016\/j.ijcard.2017.12.102_bb0245","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3109\/15622975.2010.488273","article-title":"The safety and tolerability of clozapine in aged patients: a retrospective clinical file review","volume":"11","author":"O'Connor","year":"2010","journal-title":"The World Journal Of Biological Psychiatry : The Official Journal of the World Federation of Societies of Biological Psychiatry."},{"issue":"3","key":"10.1016\/j.ijcard.2017.12.102_bb0250","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1176\/appi.ajp.2009.09081118","article-title":"Successful clozapine retrial after suspected myocarditis","volume":"167","author":"Rosenfeld","year":"2010","journal-title":"Am. J. Psychiatr."},{"issue":"7","key":"10.1016\/j.ijcard.2017.12.102_bb0255","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4088\/JCP.09l05692yel","article-title":"Clozapine rechallenge following clozapine-induced pericarditis","volume":"71","author":"Crews","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.ijcard.2017.12.102_bb0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/JCP.0b013e3181ca3c99","article-title":"Clozapine-lnduced myocarditis: 2 case reports","volume":"30","author":"Grgas","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.ijcard.2017.12.102_bb0265","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/jmri.21988","article-title":"Cardiovascular magnetic resonance in mild to moderate clozapine-induced myocarditis: is there a role in the absence of electrocardiographic and echocardiographic abnormalities?","volume":"31","author":"Ariyarajah","year":"2010","journal-title":"J. Magn. Reson. Imaging"},{"issue":"1","key":"10.1016\/j.ijcard.2017.12.102_bb0270","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/00048674.2010.533365","article-title":"Successful clozapine rechallenge after acute myocarditis","volume":"45","author":"Bray","year":"2011","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.ijcard.2017.12.102_bb0275","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/10398562.2011.580749","article-title":"Monitoring in clozapine rechallenge after myocarditis","volume":"19","author":"Hassan","year":"2011","journal-title":"Australasian Psychiatry."},{"issue":"4","key":"10.1016\/j.ijcard.2017.12.102_bb0280","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0030-1266074","article-title":"The risk for myocarditis of clozapine and other atypical antipsychotics: case report and study of the literature","volume":"38","author":"Adamaszek","year":"2011","journal-title":"Psychiatr. Prax."},{"issue":"6","key":"10.1016\/j.ijcard.2017.12.102_bb0285","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3109\/00048674.2011.572852","article-title":"A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls","volume":"45","author":"Ronaldson","year":"2011","journal-title":"Australian & New Zealand Journal of Psychiatry."},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0290","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1039856211432482","article-title":"The difficulties of diagnosing clozapine myocarditis: damned if you do, damned if you don't","volume":"20","author":"Power","year":"2012","journal-title":"Australasian Psychiatry."},{"issue":"1","key":"10.1016\/j.ijcard.2017.12.102_bb0295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.rbp.2012.10.005","article-title":"Successful re-exposure to clozapine after eosinophilia and clinically suspected myocarditis","volume":"35","author":"Granja-Ingram","year":"2013","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"12","key":"10.1016\/j.ijcard.2017.12.102_bb0300","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/0004867413502095","article-title":"Clozapine-induced pneumonitis","volume":"47","author":"Aldridge","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.ijcard.2017.12.102_bb0305","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/ehjci\/jes222","article-title":"Multimodality cardiac imaging in clozapine-induced eosinophilic constrictive perimyocarditis","volume":"14","author":"Albouaini","year":"2013","journal-title":"European Heart Journal Cardiovascular Imaging."},{"issue":"3","key":"10.1016\/j.ijcard.2017.12.102_bb0310","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1039856213475684","article-title":"Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience","volume":"21","author":"Murch","year":"2013","journal-title":"Australasian Psychiatry"},{"key":"10.1016\/j.ijcard.2017.12.102_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3371\/CSRP.ITAR.091313","article-title":"Rapid re-challenge with clozapine following pronounced myocarditis in a treatment-resistance schizophrenia patient","author":"Ittasakul","year":"2013","journal-title":"Clinical Schizophrenia & Related Psychoses."},{"key":"10.1016\/j.ijcard.2017.12.102_bb0320","doi-asserted-by":"crossref","first-page":"513108","DOI":"10.1155\/2014\/513108","article-title":"Clozapine-induced myocarditis: is mandatory monitoring warranted for its early recognition?","volume":"2014","author":"Munshi","year":"2014","journal-title":"Case Reports Psychiatry."},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/cap.2013.0098","article-title":"Successful rechallenge of clozapine therapy following previous clozapine-induced myocarditis confirmed on cardiac MRI","volume":"24","author":"Chow","year":"2014","journal-title":"Journal of Child and Adolescent Psychopharmacology."},{"key":"10.1016\/j.ijcard.2017.12.102_bb0330","first-page":"2383","article-title":"Myocarditis after administration of clozapine","volume":"18(16)","author":"Kontoangelos","year":"2014","journal-title":"European Review for Medical & Pharmacological Sciences"},{"key":"10.1016\/j.ijcard.2017.12.102_bb0335","series-title":"Monaldi Archives for Chest Disease=Archivio Monaldi per le Malattie del torace\/Fondazione Clinica del Lavoro, IRCCS [and] Istituto di Clinica Tisiologica e Malattie Apparato Respiratorio, Universita di Napoli, Secondo Ateneo","first-page":"202","article-title":"Rare case of acute clozapine-related thrombogenic myocarditis","volume":"82(4)","author":"Evangelista","year":"2014"},{"issue":"6","key":"10.1016\/j.ijcard.2017.12.102_bb0340","first-page":"1","article-title":"Clozapine-induced myocarditis and pericarditis","volume":"21","author":"Othman","year":"2014","journal-title":"Journal"},{"key":"10.1016\/j.ijcard.2017.12.102_bb0345","series-title":"Clozapine-Induced Myocarditis Proceedings of UCLA Healthcare","volume":"19","author":"Gan","year":"2015"},{"key":"10.1016\/j.ijcard.2017.12.102_bb0350","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/482375","article-title":"Clozapine-induced myocarditis: a case report of an adolescent boy with intellectual disability","volume":"2015","author":"Aboueid","year":"2015","journal-title":"Case Reports in Psychiatry"},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0355","doi-asserted-by":"crossref","first-page":"155","DOI":"10.14503\/THIJ-13-3633","article-title":"Clozapine-induced myocarditis: recognizing a potentially fatal adverse reaction","volume":"42","author":"Hatton","year":"2015","journal-title":"Tex. Heart Inst. J."},{"issue":"6","key":"10.1016\/j.ijcard.2017.12.102_bb0360","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/1039856214553314","article-title":"Asymptomatic myocarditis during clozapine re-titration, in a patient who had previously been stable on clozapine for 10years","volume":"22","author":"Smith","year":"2015","journal-title":"Australasian Psychiatry"},{"issue":"3","key":"10.1016\/j.ijcard.2017.12.102_bb0365","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/0004867414557162","article-title":"Late onset myocarditis with clozapine use","volume":"49","author":"Tan","year":"2015","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.ijcard.2017.12.102_bb0370","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/283156","article-title":"A case of clozapine-induced myocarditis in a young patient with bipolar disorder","volume":"2015","author":"Cohen","year":"2015","journal-title":"Case Reports in Cardiology."},{"key":"10.1016\/j.ijcard.2017.12.102_bb0375","series-title":"Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists","article-title":"C-reactive protein: an early critical sign of clozapine-related myocarditis","author":"Fehily","year":"2015"},{"issue":"5","key":"10.1016\/j.ijcard.2017.12.102_bb0380","doi-asserted-by":"crossref","DOI":"10.4212\/cjhp.v68i5.1493","article-title":"Clozapine-associated myocarditis: case report and literature review","volume":"68","author":"Barry","year":"2015","journal-title":"The Canadian Journal of Hospital Pharmacy"},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0385","doi-asserted-by":"crossref","first-page":"82","DOI":"10.9740\/mhc.2015.03.082","article-title":"Clozapine-induced myocarditis may warrant cardiac monitoring protocol","volume":"5","author":"Miller","year":"2015","journal-title":"The Mental Health Clinician"},{"issue":"9","key":"10.1016\/j.ijcard.2017.12.102_bb0390","first-page":"19","article-title":"Clozapine-associated myocarditis","volume":"145","author":"Molina Martin de Nicolas","year":"2015","journal-title":"Medicina Clinica"},{"key":"10.1016\/j.ijcard.2017.12.102_bb0395","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1177\/0004867415585584","article-title":"Heterogeneity of clozapine-associated myocarditis: an opportunity for novel preventing strategies","volume":"49","author":"Baptista","year":"2015","journal-title":"The Australian and New Zealand Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.ijcard.2017.12.102_bb0400","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0091217415621269","article-title":"Clozapine-induced myocarditis may be associated with rapid titration: a case report verified with autopsy","volume":"51","author":"Chopra","year":"2016","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.ijcard.2017.12.102_bb0405","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2016.04.016","article-title":"Clozapine-induced myocarditis","volume":"174","author":"Swart","year":"2016","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0410","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5455\/bcp.20151216022322","article-title":"Sudden death associated with hypersensitivity myocarditis induced by clozapine: an autopsy case","volume":"26","author":"Es","year":"2016","journal-title":"Klinik Psikofarmakoloji Bulteni."},{"key":"10.1016\/j.ijcard.2017.12.102_bb0415","doi-asserted-by":"crossref","first-page":"4159081","DOI":"10.1155\/2016\/4159081","article-title":"Lessons learned and questions raised by an atypical case of clozapine-induced myocarditis","volume":"2016","author":"Earnshaw","year":"2016","journal-title":"Case Reports Psychiatry."},{"issue":"7296","key":"10.1016\/j.ijcard.2017.12.102_bb0420","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/bmj.322.7296.1207","article-title":"Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study","volume":"322","author":"Coulter","year":"2001","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ijcard.2017.12.102_bb0425","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/hrt.2004.045518","article-title":"Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death","volume":"92","author":"Fabre","year":"2006","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0430","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4088\/JCP.11l07467","article-title":"Observations from 8 cases of clozapine rechallenge after development of myocarditis","volume":"73","author":"Ronaldson","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.ijcard.2017.12.102_bb0435","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1586\/14737175.7.7.829","article-title":"Cardiovascular effects of antipsychotics","volume":"7","author":"Michelsen","year":"2007","journal-title":"Expert. Rev. Neurother."},{"issue":"supp 3","key":"10.1016\/j.ijcard.2017.12.102_bb0440","first-page":"38","article-title":"Maximizing clozapine therapy: managing side effects","volume":"59","author":"Lieberman","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.ijcard.2017.12.102_bb0445","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/schbul\/17.2.247","article-title":"Update on the clinical efficacy and side effects of clozapine","volume":"17","author":"Safferman","year":"1991","journal-title":"Schizophr. Bull."},{"issue":"33","key":"10.1016\/j.ijcard.2017.12.102_bb0450","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2017.12.102_bb0455","series-title":"The Maudsley Prescribing Guidelines in Psychiatry (12)","author":"Taylor","year":"2015"},{"issue":"2\u20133","key":"10.1016\/j.ijcard.2017.12.102_bb0460","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2012.08.018","article-title":"Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study","volume":"141","author":"Ronaldson","year":"2012","journal-title":"Schizophr. Res."},{"issue":"Suppl1","key":"10.1016\/j.ijcard.2017.12.102_bb0465","first-page":"20","article-title":"Metabolic considerations in the use of antipsychotic medications: a review of recent evidence","volume":"68","author":"Newcomer","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ijcard.2017.12.102_bb0470","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/acps.12416","article-title":"Clozapine-induced myocarditis, a widely overlooked adverse reaction","volume":"132","author":"Ronaldson","year":"2015","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ijcard.2017.12.102_bb0475","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1176\/ajp.152.3.453","article-title":"Schizophrenia and smoking: an epidemiological 9 survey in a state hospital","volume":"152","author":"Jose de Leon","year":"1995","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.ijcard.2017.12.102_bb0480","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/oxfordjournals.schbul.a033504","article-title":"Prevalence and correlates of diabetes in national schizophrenia samples","volume":"26","author":"Dixon","year":"2000","journal-title":"Schizophr. Bull."}],"updated-by":[{"DOI":"10.1016\/j.ijcard.2018.03.091","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T00:00:00Z","timestamp":1531612800000}}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317321459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317321459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T06:01:19Z","timestamp":1719900079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317321459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":96,"alternative-id":["S0167527317321459"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.12.102","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijcard.2018.03.091","asserted-by":"object"}]},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of clozapine-induced myocarditis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.12.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}